BTT-1023 in Rheumatoid Arthritis

NCT00851240 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: BTT-1023
DRUG: Placebo

Sponsor

Biotie Therapies Corp.